BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10022533)

  • 1. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
    Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
    Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.
    Frisella WA; O'Connor LH; Vogler CA; Roberts M; Walkley S; Levy B; Daly TM; Sands MS
    Mol Ther; 2001 Mar; 3(3):351-8. PubMed ID: 11273777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus.
    Watson GL; Sayles JN; Chen C; Elliger SS; Elliger CA; Raju NR; Kurtzman GJ; Podsakoff GM
    Gene Ther; 1998 Dec; 5(12):1642-9. PubMed ID: 10023443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
    Wang B; O'Malley TM; Xu L; Vite C; Wang P; O'Donnell PA; Ellinwood NM; Haskins ME; Ponder KP
    Mol Genet Metab; 2006 Jan; 87(1):8-21. PubMed ID: 16275036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
    Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y
    Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.
    Daly TM; Vogler C; Levy B; Haskins ME; Sands MS
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2296-300. PubMed ID: 10051635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
    Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
    Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread correction of lysosomal storage in the mucopolysaccharidosis type VII mouse brain with a herpes simplex virus type 1 vector expressing beta-glucuronidase.
    Berges BK; Yellayi S; Karolewski BA; Miselis RR; Wolfe JH; Fraser NW
    Mol Ther; 2006 May; 13(5):859-69. PubMed ID: 16515890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.
    Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR
    Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
    Zhu J; Kang W; Wolfe JH; Fraser NW
    Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
    Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
    Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer.
    Daly TM; Ohlemiller KK; Roberts MS; Vogler CA; Sands MS
    Gene Ther; 2001 Sep; 8(17):1291-8. PubMed ID: 11571565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.
    Bosch A; Perret E; Desmaris N; Heard JM
    Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.
    Hennig AK; Ogilvie JM; Ohlemiller KK; Timmers AM; Hauswirth WW; Sands MS
    Mol Ther; 2004 Jul; 10(1):106-16. PubMed ID: 15233947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level expression and export of beta-glucuronidase from murine mucopolysaccharidosis VII cells corrected by a double-copy retrovirus vector.
    Wolfe JH; Kyle JW; Sands MS; Sly WS; Markowitz DG; Parente MK
    Gene Ther; 1995 Jan; 2(1):70-8. PubMed ID: 7712336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
    Gao C; Sands MS; Haskins ME; Ponder KP
    Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression.
    Kosuga M; Takahashi S; Sasaki K; Li XK; Fujino M; Hamada H; Suzuki S; Yamada M; Matsuo N; Okuyama T
    Mol Ther; 2000 May; 1(5 Pt 1):406-13. PubMed ID: 10933961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII.
    Bielicki J; McIntyre C; Anson DS
    Mol Genet Metab; 2010 Dec; 101(4):370-82. PubMed ID: 20864369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice.
    Elliger SS; Elliger CA; Lang C; Watson GL
    Mol Ther; 2002 May; 5(5 Pt 1):617-26. PubMed ID: 11991753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
    Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
    Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.